Stock listing

Frankfurt:DV3R Delcath Systems, Inc. Aktie

German listing (Frankfurt) of Delcath Systems, Inc. · home listing NASDAQ:DCTH

Follow Delcath Systems, Inc. into a list and get an email when it puts out news.

Share price · FWB:DV3R

€12.55 EUR -0.29 (-2.2%)

Close on Oct 30, 2026

Day range
€12.55 – €12.70 EUROct 30, 2026
Volume
130 sharesOct 30, 2026
Delcath Systems, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:DCTH · Home$14.04 USD-0.60 (-4.1%)427,049$14.64$15.24$13.92$14.64Close on Oct 30, 2026
Frankfurt:DV3R€12.55 EUR-0.285 (-2.2%)130€12.62€12.70€12.55€12.83Close on Oct 30, 2026
Ticker
Frankfurt:DV3R
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Upcoming

  • Delcath Systems (NASDAQ:DCTH) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 8:30 AM ET

    Register

Replays

  • Delcath Systems (NASDAQ:DCTH) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Delcath Systems (NASDAQ:DCTH) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

  • Delcath Systems (NASDAQ:DCTH) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:30 PM ET

    Watch Transcript

Latest news

Delcath Systems to Participate in Upcoming Investor Conferences

Oct 27, 2026

Delcath Systems to Host Third Quarter 2026 Earnings Call

Oct 26, 2026

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Oct 19, 2026

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

Aug 6, 2026

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

Jul 28, 2026

Delcath Systems to Host Second Quarter 2026 Earnings Call

Jul 23, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer

Jul 10, 2026

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts

May 26, 2026

Delcath Systems Reports First Quarter 2026 Results and Business Highlights

May 7, 2026

Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026

May 7, 2026

All Delcath Systems, Inc. news

Decks

Delcath Systems, Inc. on 6ix

News releases
27 in the last 12 months · 135 in all · newest Oct 27, 2026 · oldest 2019
Calls
21 calls with a replay · 21 with a transcript · latest Aug 6, 2026
Decks
59 decks · latest Aug 6, 2026

Where Delcath Systems, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:DCTH · Home listingNASDAQUnited StatesUSD
gettex:DV3RgettexGermanyEUR
LS Exchange:A2PT5PLS ExchangeGermanyEUR
Lang & Schwarz:A2PT5PLang & SchwarzGermanyEUR
Tradegate:DV3RTradegateGermanyEUR
BOATS:DCTHBOATSUnited StatesUSD
Frankfurt:DV3R · This pageFrankfurtGermanyEUR
Dusseldorf:DV3RDusseldorfGermanyEUR
Munich:DV3RMunichGermanyEUR
Stuttgart:DV3RStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Delcath Systems, Inc.